.png){kind=icon}
.png){kind=icon}
Return
Imaging of De Novo Malignancy after Solid Organ Transplant
.png){kind=icon}
PRE
AI
H
T
R
P
K
K
DOI：10.1148/radiol.251384.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The life expectancy of solid organ transplant recipients has improved over the years because of advanced immunosuppressive regimens, improved anti-infectious agents, and aggressive prophylactic treatments that have decreased the risk of acute rejection and organ loss, life-threatening infections, and cardiovascular events. In comparison, malignancy has increasingly become the leading cause of morbidity and mortality in patients with solid organ transplants. Noninvasive imaging after organ transplantation aids in detecting tumors, planning treatments, and monitoring for complications, thereby leading to improved outcomes. This article discusses the pathogenesis, classification, and imaging findings of de novo posttransplant malignancies. (c) RSNA, 2026
Keywords:
MERKEL CELL-CARCINOMA
KAPOSIS-SARCOMA
LYMPHOPROLIFERATIVE DISORDER
IMMUNOSUPPRESSIVE THERAPY
KIDNEY-TRANSPLANTATION
CLINICAL-FEATURES
SKIN-CANCER
RISK
PREDICTORS
MELANOMA
Journal
IF:
15.2
Papers:
4.0W
Citations:
6.0W
Organization
Cited Papers